Expert Interview
Discussing Innovent's Mazdutide, a dual GCG/GLP-1 receptor agonist recently approved in China for chronic weight management
Ticker(s): INNOVENT, LLY, NVOInstitution: Luminis Health
- Endocrinologist at Luminis Health in Annapolis, MD
- Treats over 900 patients per year with obesity.
- KOL and research expert on MC4R Agonist's an other pathways to addressing obesity.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
